Ng Investing

Published September 21, 2026 · Updated September 22, 2026

Helus Pharma presents data on depression drug candidate HLP003 - Investing.com Nigeria

Read the full story at Ng Investing

Morial Convention Center in New Orleans, according to a press release statement. ... psychedelic experience during the Phase 1/2a study, expanded.